Etoruexa MR Tablet is a combination medication containing Etoricoxib 60mg and Thiocolchicoside 4mg, designed to provide effective relief from pain and inflammation associated with musculoskeletal conditions. Etoricoxib is a selective COX-2 inhibitor that helps reduce inflammation and pain by blocking the cyclooxygenase-2 enzyme, which plays a key role in the inflammatory process. Thiocolchicoside is a muscle relaxant that acts on the central nervous system to relieve muscle spasms and stiffness, improving mobility and comfort. This combination is particularly beneficial for patients suffering from acute musculoskeletal disorders such as lower back pain, osteoarthritis, rheumatoid arthritis, and muscle strains. Etoruexa MR Tablet offers the advantage of sustained release, ensuring prolonged therapeutic effects and better patient compliance by reducing the frequency of dosing. It is generally well-tolerated but should be used under medical supervision, especially in individuals with a history of cardiovascular issues, gastrointestinal problems, or liver and kidney impairment. Patients are advised to follow the prescribed dosage and consult their healthcare provider if they experience any adverse effects or if symptoms persist. Overall, Etoruexa MR Tablet provides a balanced approach to managing pain and muscle spasm, enhancing patient quality of life.